Aptevo Therapeutics (APVO) Stock on a roll after Tang Capital Partners Discloses 54.40% Stake in APVO
Aptevo stock is trading in its highest range since Oct. 2018 as the biotech firm updates on completeremission of APVO436 while Tang discloses its stake in the company. The clinical-stage biotech firm, Aptevo Therapeutics Inc. (APVO) shares are on a roll from the start of this